8
listopada

4th International cGvHD Symposium and TCWP Educational Meeting, Zagrzeb

rok: 2018 czas trwania: 2 dni zakończenie: 2018-11-10

Serdecznie zapraszamy na 4th International cGvHD Symposium and TCWP Educational Meeting, które odbędzie się w dniach 8-10 listopada w Zagrzebiu.

PROGRAM

Thursday November 8th 

16.00-18.00: Registration of participants
16.00-20.00: EBMT Transplant Complications WP business meeting

Friday, November 9th: 4 th cGVHD International Symposium

07.30-08.15: Registration of participants
08.15-08.30: S.Z. Pavletic (USA), G. Basak (Poland) and D. Pulanić (Croatia): Opening and Introduction to the Symposium and Meeting

1) General principles and current knowledge about cGVHD

a) Biology, biomarkers and epidemiology (chairs Prof. Mohty (France), Prof. Batinić (Croatia))

8.30-8.50 Prof. Pavletic (USA): Chronic GVHD as an evolving clinical problem
8.50-9.10 Prof. Greinix (Austria): Biology of cGVHD
9.10-9.30 Prof. Wolff (Germany): Biomarkers in cGVHD – quo vaditis?

b) Clinical diagnosis and management (chairs Prof. Kröger (Germany), Dr. Serventi Seiwerth (Croatia))

9.30-9.50 Prof. Vrhovac (Croatia): Diagnosis and staging of cGVHD since 2014 NIH criteria
9.50-10.10 Prof. Duarte (Spain): Front line systemic therapy for cGVHD
10.10-10.30 Prof. Halter (Switzerland): Salvage systemic therapy for cGVHD
10.30-10.50 Prof. Olivieri (Italy): Response criteria in cGVHD
10.50-11.10 Prof. Lawitschka (Austria): Pediatric aspects of cGVHD
11.10-11.30 Coffee break

2) a) New issues regarding particular aspects of cGVHD – 1 st part (chairs Prof. Wolff, (Germany), Dr. Desnica (Croatia))

11.30-11.50 Prof. Mohty (France): Microbiome in GVHD/GVL
11.50-12.10 Prof. Kröger (Germany): Prevention of cGVHD
12.10-12.30 Prof. Bilić (Croatia): Peripheral neuropathy in cGVHD
12:30-13:00 Lunch Break

Therakos Symposium including lunch (optional)
Prof Hildegard Greinix: “GVHD–Clinical evidence of ECP-mediated immunomodulation”
Prof. Bipin Savani: “How we manage late effects after hematopoietic cell transplantation”
This is a commercial programme run by Therakos (UK) Ltd, a Mallinckrodt Company

2) b) New issues regarding particular aspects of cGVHD – 2 nd part (chairs Prof. Basak, (Poland), Assist. Prof. Pulanić (Croatia))

14.00-14.20 Prof. Mravak-Stipetić (Croatia): Oral cGVHD
14.20-14.40 Assist. Prof. Petriček (Croatia): Ocular cGVHD
14.40-15.00 Dr. Pučić Baković (Croatia): Glycans in cGVHD

3. Clinical trials design and drug development (chairs Prof. Pavletic (USA), Prof. Zadro (Croatia))

15.00-15.25 Dr. Baird (USA): Regulatory challenges in conducting studies in cGVHD
15.25-15.50 Assist. Prof. Pusic (USA): Logistical challenges in conducting studies in cGVHD
15.50-16.15 Panel Discussion (Moderators: Prof. Halter (Switzerland), Prof. Olivieri (Italy), Prof. Lawitschka (Austria), Dr. Bojanić (Croatia)) 16.15-16.45 Coffee break

4. Implementation challenges (chairs Prof. Duarte (Spain), Assist. Prof. Duraković (Croatia))

16.45-17.00 Dr. Schoemans (Belgium): Modern technology in cGVHD evaluation
17.00-17.15 Assist. Prof. Pulanić (Croatia): Need for multidisciplinary approach - 5 years of multidisciplinary cGVHD team in Zagreb

5. Presentation and discussion of case reports (chairs Prof. Greinix (Austria), Prof. Vrhovac (Croatia))

17.15-17.25 Dr. Serventi Seiwerth (Croatia): A case report I – severe cGVHD on topical treatment
17.25-17.35 Dr. Desnica (Croatia): A case report II – male urogenital cGVHD
17.35-17.45 Dr. Perić (Croatia): A case report III – renal cGVHD
17.45.-17.55 Dr. Klepac Pulanić (Croatia): A case report IV – gynecological cGVHD
19.00-21.00 Networking reception and dinner

Saturday, November 10th

09.00-16.30: EBMT Transplant Complications Working Party Educational course
9.00-9.10 Introduction (G. Basak (Poland), Z. Perić (Croatia))

I. Early complications and supportive care [Chairs: Christian Koenecke, Tapani Ruutu]

9.10-9.30 Transplant-associated microangiopathy: Olaf Penack
9.30-9.50 Management of conditioning-related organ toxicities: Christian Koenecke
9.50-10.10 Venoocclussive disease (VOD): Rafael Duarte
10.10-10.20 Case: Junior presenter (grant)
10.20-10.40 Coffee break

II. Late effects [Chairs Helene Schoemans, Nina Salooja]

10.40 – 11.00 Ocular complications: Sharukh Hashmi
11.00-11.20 Pregnancy after HSCT: Nina Salooja
11.20- 11.40 Managing sexual problems after transplantation: Corien Eeltink
11.40 – 11.50 Case: Junior presenter (grant)

Symposium kindly supported by Incyte, Chair: Rafael Duarte New avenues for treatment of GVHD

11:50-11:55 Welcome & Introductions: Rafael Duarte
11:55-12:20 Molecular pathways implicated in acute and chronic GVHD – preclinical perspective: Robert Zeiser
12:20-12:45 Treatments for GVHD: where are we at?: Rafael Duarte
12:45-12:50 Panel Discussion
12:50-13:20 Lunch kindly supported by Incyte

III. Acute GvHD [Chairs Olaf Penack, Hildegard Greinix]

13.20-13.40 Standard and emerging treatments of acute GVHD: Hildegard Greinix
13.40-14.00 Alloreactivity in organs other than skin, gut and liver: Jacopo Mariotti
14.00-14.10 Case: Junior presenter (grant)
14:10-14:30 Coffee Break

IV. Novel treatments of transplant complications [Chairs Grzegorz Basak, Zinaida Peric]

14.30-14.50 Role of physical therapy: Jaleel Mohammed
14.50-15.10 Diagnosis and treatment of cytokine-release syndrome: Zinaida Peric
15:10-15:30 Complement inhibitors: Ivan Moiseev
15.30- 15.50 Fecal microbiota transplantation: Grzegorz Basak
15.50-16.00: Closing of the meeting: G.W. Basak, Z. Perić, R. Vrhovac, S.Z. Pavletic, D. Pulanić

Organizing Committee:
Basak Grzegorz W. (Warsaw, Poland) – Transplant Complications WP,
EBMT Perić Zinaida (Zagreb, Croatia) – Transplant Complications WP,
EBMT Vrhovac Radovan (Zagreb, Croatia) – 4 th International cGVHD
Symposium Pavletic Steven Z. (Bethesda, MD, USA) – 4 th International cGVHD
symposium Pulanić Dražen (Zagreb, Croatia) – 4 th International cGVHD Symposium

ikona Info Oficjalna strona wydarzenia

 

Wróć do kalendarza
kodowanie: projekt: